Funder: Cancer Research UK

Due Dates (Anticipated): January 2026 (Expression of Interest) | April 2026 (Full Proposal) | May 2026 (Interview) | June 2026 (Outcome)

Funding Amounts: Up to £250,000 for up to 18 months per project; milestone-driven funding with possible in-kind support.

Summary: Supports collaborative, translational research to accelerate early-stage drug discovery for novel childhood cancer therapeutics.

Key Information: Open to international applicants; projects must be collaborative with Cancer Research Horizons’ drug discovery labs.